US equities
|
MU
$938.32
▼-5.13%
META
$766.60
▲+3.18%
NVDA
$225.05
▼-0.56%
SNDK
$1,436.66
▼-3.41%
AAPL
$346.10
▲+1.50%
MSFT
$547.73
▲+1.22%
SPCX
$156.74
▼-4.09%
AMD
$587.99
▼-1.05%
MU
$938.32
▼-5.13%
META
$766.60
▲+3.18%
NVDA
$225.05
▼-0.56%
SNDK
$1,436.66
▼-3.41%
AAPL
$346.10
▲+1.50%
MSFT
$547.73
▲+1.22%
SPCX
$156.74
▼-4.09%
AMD
$587.99
▼-1.05%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Heartflow, Inc. - Common Stock
(NQ:
HTFL
)
50.85
+0.29 (+0.57%)
Delayed Quote
Updated: 11:07 AM EDT, Oct 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Heartflow, Inc. - Common Stock
< Previous
1
2
3
Next >
Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026
April 23, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
April 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
USA News Group
Via
GlobeNewswire
Heartflow Files Patent Infringement Lawsuit Against Cleerly
April 13, 2026
Heartflow asserts that Cleerly infringed foundational patented technology central to the Heartflow Platform
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow Inc (NASDAQ:HTFL) Reports Strong Q4 Revenue Beat and Improved Margins Despite After-Hours Share Decline
↗
March 18, 2026
Via
Chartmill
What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale
↗
March 25, 2026
HeartFlow delivers AI-powered cardiac diagnostics to hospitals worldwide; a key insider recently trimmed their stake, SEC filings show.
Via
The Motley Fool
Topics
Artificial Intelligence
Regulatory Compliance
Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?
↗
March 22, 2026
HeartFlow delivers AI-powered, non-invasive cardiac diagnostics to healthcare providers seeking advanced imaging and decision support tools.
Via
The Motley Fool
Heartflow Reports Fourth Quarter and Full Year 2025 Financial Results
March 18, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning
March 16, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference
February 18, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
February 13, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow Expands GAMEFILM Registry to NBA and NHL Alumni, Precisely Measuring Heart Disease Risk in Former Professional Athletes
February 12, 2026
NBA legend Muggsy Bogues joins effort to detect and manage coronary artery disease in retired players using AI-powered Heartflow Analysis
From
Heartflow, Inc.
Via
GlobeNewswire
EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes
↗
February 04, 2026
CEO Brent Ness noted a broad global market, with approximately 266 million people affected by chronic low back pain.
Via
Stocktwits
Topics
Artificial Intelligence
AI Diagnostics: The End of the High-Cost Imaging Era
January 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.
January 06, 2026
Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque Analysis
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Is Recent IPO Stock Heartflow a Buy After a Director Scooped Up Shares Worth Over $1 Million?
↗
December 28, 2025
AI-powered cardiac diagnostics firm HeartFlow reported a recent insider buy, as disclosed in the latest SEC filing.
Via
The Motley Fool
Topics
Artificial Intelligence
Initial Public Offering
Regulatory Compliance
Why AI Stock HeartFlow Triumphed on Thursday
↗
December 18, 2025
A key FDA-cleared analysis tool earned professional accolades for its utility.
Via
The Motley Fool
Topics
Artificial Intelligence
Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD
December 18, 2025
Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease
December 11, 2025
Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England’s National Health Service
From
Heartflow, Inc.
Via
GlobeNewswire
This Family Office Acquired $148 Million of Karman Stock as Shares Tripled Since February IPO
↗
November 30, 2025
One family office fund just made Karman its biggest reported equity bet—here’s what long-term investors should take from the move.
Via
The Motley Fool
Topics
Regulatory Compliance
Supply Chain
Billionaire Family Office Acquires $65 Million of HeartFlow as Stock Jumps 70% From IPO
↗
November 30, 2025
A billionaire family office has made a big bet on a newly public AI-driven heart diagnostics company—here’s what long-term investors should take from the move.
Via
The Motley Fool
Topics
Artificial Intelligence
Initial Public Offering
Regulatory Compliance
Investment Powerhouse Backs Biotech Stock to the Tune of $419 Million
↗
November 20, 2025
Bain Capital added more than 12.4 million shares of HeartFlow stock in the thrid quarter
Via
The Motley Fool
Topics
Artificial Intelligence
Regulatory Compliance
Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer
↗
November 20, 2025
Bain Capital's bet on Cidara Therapeutics stocks has paid off in a big way
Via
The Motley Fool
Topics
Regulatory Compliance
Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
From
Heartflow, Inc.
Via
GlobeNewswire
Biotech Stock Gets Booted in Latest Fund Update
↗
November 19, 2025
Bain Capital sold its entire stake in Nuvalent stock during the third quarter.
Via
The Motley Fool
Topics
Regulatory Compliance
Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock
↗
November 19, 2025
Bain Capital completely exited its position in Disc Medicine stock during the third quarter
Via
The Motley Fool
Why Bain Capital Is Selling Shares of This Biotech Stock Now
↗
November 18, 2025
Bain Capital sold $20 million worth of Pharvaris stock during the third quarter.
Via
The Motley Fool
Topics
Regulatory Compliance
Where Innovation Meets the Heart: Stanford’s New Position in HeartFlow
↗
November 17, 2025
Stanford just bought into HeartFlow. Here is what caught Stanford’s eye and what investors need to know about HeartFlow’s early trajectory and long-term potential.
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Heartflow Inc (NASDAQ:HTFL) Posts Mixed Q3 2025 Results with Strong Revenue Beat and Upbeat Guidance
↗
November 12, 2025
Heartflow Q3 2025 earnings show strong revenue growth, beating estimates, and confident full-year guidance.
Via
Chartmill
Heartflow Reports Third Quarter 2025 Financial Results
November 12, 2025
Initiates Full Year 2025 Revenue Guidance of $173.0 Million to $173.5 Million
From
Heartflow, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
